Top Authors

• Most frequent coverage on RGN

• 
  Mike Havrilla (1934 followers)

  • Expecting Post-Stimulus Catalyst for Stem Cell Research Companies (Mon, Feb 16)

  More by Mike Havrilla on RGN »
• 
  Fritz Hottinger (85 followers)

  • RegeneRx: A Beaten Down Biotech (Fri, Nov 28)

  More by Fritz Hottinger on RGN »
• 
  Michael Becker (165 followers)

  • Cash for Cardiovascular: Who Might Be Next? (Wed, Aug 12)

  More by Michael Becker on RGN »

• Most followed authors on RGN

• 
  Mike Havrilla (1934 followers)

  • Expecting Post-Stimulus Catalyst for Stem Cell Research Companies (Mon, Feb 16)

  More by Mike Havrilla on RGN »
• 
  Michael Becker (165 followers)

  • Cash for Cardiovascular: Who Might Be Next? (Wed, Aug 12)

  More by Michael Becker on RGN »
• 
  Fritz Hottinger (85 followers)

  • RegeneRx: A Beaten Down Biotech (Fri, Nov 28)

  More by Fritz Hottinger on RGN »

• Newest authors on RGN

• 
  Michael Becker (165 followers)

  • Cash for Cardiovascular: Who Might Be Next? (Wed, Aug 12)

  More by Michael Becker on RGN »
• 
  Fritz Hottinger (85 followers)

  • RegeneRx: A Beaten Down Biotech (Fri, Nov 28)

  More by Fritz Hottinger on RGN »
• 
  Mike Havrilla (1934 followers)

  • Expecting Post-Stimulus Catalyst for Stem Cell Research Companies (Mon, Feb 16)

  More by Mike Havrilla on RGN »

• Most commented on RGN

• 
  Mike Havrilla (1934 followers)

  • Expecting Post-Stimulus Catalyst for Stem Cell Research Companies (Mon, Feb 16)

  More by Mike Havrilla on RGN »
• 
  Fritz Hottinger (85 followers)

  • RegeneRx: A Beaten Down Biotech (Fri, Nov 28)

  More by Fritz Hottinger on RGN »
• 
  Michael Becker (165 followers)

  • Cash for Cardiovascular: Who Might Be Next? (Wed, Aug 12)

  More by Michael Becker on RGN »